The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.10 - Manufacture of basic pharmaceutical products
100 jobs Number of planned job creations
Announcement Date
2 April 2015
Employment effect (start)
1 May 2015
Foreseen end date
31 May 2018
Description
Pharmaceutical products manufacturer GlaxoSmithKline (GSK) has announced to recruit about 100 employees between now and 2018 at its Saint-Amand-les-Eaux site which currently employs 680 people. The group want to invest 6 million to produce a malaria vaccine. The company's vaccines production platform has received EUR 600mn in investments since 2006.
Sources
2 April 2015: L'usine Nouvelle
Citation
Eurofound (2015), GlaxoSmithKline (GSK), Business expansion in France, factsheet number 83611, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/83611.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
